Peptide-based Immunotherapy
Peptide-Based Immunotherapy is a therapeutic strategy within antigen-specific immunotherapy that utilizes short, synthetic peptide fragments derived from target allergens or autoantigens to modulate immune responses by inducing tolerance or desensitization without eliciting adverse inflammatory reactions.
508
Publications
32.2K
Citations
3.3K
Authors
903
Institutions
Publications per year
2017–2026
99
508
Akihiro Tsuboi, Tetsuya Taguchi, Tadashi Osaki et al. · Proceedings of the National Academy of Sciences · 2004 · 526 citations · Full text
Medicine, Immunology, Oncology +17
Martha A. Alexander‐Miller, Graham R. Leggatt, J A Berzofsky · Proceedings of the National Academy of Sciences · 1996 · 507 citations · Full text
1–5 of 508
3.3K
15
h-index
13
h-index
12
h-index
10
h-index
9
h-index
1–5 of 3.3K
903
Kurume University
Kurume, Japan
16 h-index
117 publications
4.4K citations
Inserm
Paris, France
15 h-index
65 publications
2.7K citations
National Institutes of Health
Bethesda, United States
15 h-index
96 publications
34.4K citations

Weizmann Institute of Science
Rehovot, Israel
14 h-index
46 publications
3.9K citations

University of Tübingen
Tübingen, Germany
13 h-index
75 publications
5.1K citations
Stanford University
Stanford, United States
11 h-index
42 publications
4.5K citations
The University of Osaka
Osaka, Japan
11 h-index
112 publications
17.1K citations

Imperial College London
London, United Kingdom
10 h-index
42 publications
5.2K citations
1–8 of 903
JI · 47 publications · 2.9K citations
30
h-index
Repository · 30 publications · 1.6K citations
19
h-index
PNAS · 17 publications · 2.2K citations
16
h-index
16 publications · 1.2K citations
14
h-index
11 publications · 460 citations
11
h-index
1–5